Endothelial α1-adrenoceptors regulate neo-angiogenesis

British Journal of Pharmacology

Volumn 153, Issue 5, 2008, Pages 936-946

  Ciccarelli, M ^a   Santulli, G ^a   Campanile, A ^a   Galasso, G ^a   Cervero P ^a   Altobelli, G G ^a   Cimini, V ^a   Pastore, L ^a   Piscione, F ^a   Trimarco, B ^a   Iaccarino, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Angiogenesis; Endothelium; Pharmacology; Receptors; Vascular biology

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; DOXAZOSIN; MITOGEN ACTIVATED PROTEIN KINASE; PHENYLEPHRINE; RETINOBLASTOMA PROTEIN; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CONTROLLED STUDY; DNA SYNTHESIS; DOPPLER FLOWMETRY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HINDLIMB; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIA; LOW DRUG DOSE; MALE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; ENDOTHELIUM CELL; GENE EXPRESSION; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM; VASCULARIZATION; WISTAR KYOTO RAT;

ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; CELL PROLIFERATION; DOXAZOSIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HINDLIMB; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; PHENYLEPHRINE; RATS; RATS, INBRED WKY; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 40149099168     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/sj.bjp.0707637     Document Type: Article

References (50)

1. Akhter SA, Luttrell LM, Rockman HA, Iaccarino G, Lefkowitz RJ, Koch WJ (1998). Targeting the receptor-Gq interface to inhibit in vivo pressure overload myocardial hypertrophy. Science 280: 574-577.
2. Alexandrov A, Keffel S, Goepel M, Michel MC (1998). Stimulation of alpha1A-adrenoceptors in rat-1 cells inhibits extracellular signal-regulated kinase by activating p38 mitogen-activated protein kinase. Mol Pharmacol 54: 755-760.
3. Augustin HG (2001). Tubes, branches, and pillars: the many ways of forming a new vasculature. Circ Res 89: 645-647.
4. Ben-Dov IZ, Ben-Arie L, Mekler J, Bursztyn M (2006). How should patients treated with alpha-blockers be followed? Insights from an ambulatory blood pressure monitoring database. J Hypertens 24: 861-865.
5. Benning CM, Kyprianou N (2002). Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor- independent action. Cancer Res 62: 597-602.
6. Carmeliet P (2000). Mechanisms of angiogenesis and arteriogenesis. Nat Med 6: 389-395.
7. Ciccarelli M, Cipolletta E, Santulli G, Campanile A, Pumiglia K, Cervero P et al. (2007). Endothelial beta2 adrenergic signaling to AKT: role of Gi and SRC. Cell Signal 19: 1949-1955.
8. Cooke JP, Losordo DW (2002). Nitric oxide and angiogenesis. Circulation 105: 2133-2135.
9. Dawson JM, Hudlicka O (1989). The effects of long term administration of prazosin on the microcirculation in skeletal muscles. Cardiovasc Res 23: 913-920.
10. Deshpande A, Sicinski P, Hinds PW (2005). Cyclins and cdks in development and cancer: a perspective. Oncogene 24: 2909-2915.
11. Dusseau JW, Hutchins PM, Malbasa DS (1986). Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circ Res 59: 163-170.
12. Eckhart AD, Yang N, Xin X, Faber JE (1997). Characterization of the alpha1B-adrenergic receptor gene promoter region and hypoxia regulatory elements in vascular smooth muscle. Proc Natl Acad Sci USA 94: 9487-9492.
13. Emanueli C, Salis MB, Stacca T, Gaspa L, Chao J, Chao L et al. (2001). Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer. Hypertension 38: 136-141.
14. Franke RP, Grafe M, Schnittler H, Seiffge D, Mittermayer C, Drenckhahn D (1984). Induction of human vascular endothelial stress fibres by fluid shear stress. Nature 307: 648-649.
15. Fulgenzi G, Graciotti L, Collis MG, Hudlicka O (1998). The effect of alpha 1 adrenoceptor antagonist prazosin on capillary supply, blood flow and performance in a rat model of chronic muscle ischaemia. Eur J Vasc Endovasc Surg 16: 71-77.
16. Galasso G, Schiekofer S, Sato K, Shibata R, Handy DE, Ouchi N et al. (2006). Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction. Circ Res 98: 254-261.
17. Gibson CM, Cannon CP, Daley WL, Dodge Jr JT, Alexander Jr B, Marble SJ et al. (1996). TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 93: 879-888.
18. Gong H, Sun H, Koch WJ, Rau T, Eschenhagen T, Ravens U et al. (2002). Specific beta(2)AR blocker ICI 118 551 actively decreases contraction through a G(i)-coupled form of the beta(2)AR in myocytes from failing human heart. Circulation 105: 2497-2503.
19. Guarino RD, Perez DM, Piascik MT (1996). Recent advances in the molecular pharmacology of the alpha 1-adrenergic receptors. Cell Signal 8: 323-333.
20. Guimaraes S, Moura D (2001). Vascular adrenoceptors: an update. Pharmacol Rev 53: 319-356.
21. Hudlicka O (1998). Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation 5: 5-23.
22. Iaccarino G, Barbato E, Cipolleta E, Esposito A, Fiorillo A, Koch WJ et al. (2001a). Cardiac betaARK1 upregulation induced by chronic salt deprivation in rats. Hypertension 38: 255-260.
23. Iaccarino G, Ciccarelli M, Sorriento D, Cipolletta E, Cerullo V, Iovino GL et al. (2004). AKT participates in endothelial dysfunction in hypertension. Circulation 109: 2587-2593.
24. Iaccarino G, Ciccarelli M, Sorriento D, Galasso G, Campanile A, Santulli G et al. (2005). Ischemic neoangiogenesis enhanced by beta2-adrenergic receptor overexpression: a novel role for the endothelial adrenergic system. Circ Res 97: 1182-1189.
25. Iaccarino G, Cipolletta E, Fiorillo A, Annecchiarico M, Ciccarelli M, Cimini V et al. (2002). Beta(2)-adrenergic receptor gene delivery to the endothelium corrects impaired adrenergic vasorelaxation in hypertension. Circulation 106: 349-355.
26. Iaccarino G, Keys JR, Rapacciuolo A, Shotwell KF, Lefkowitz RJ, Rockman HA et al. (2001b). Regulation of myocardial betaARK1 expression in catecholamine-induced cardiac hypertrophy in transgenic mice overexpressing alpha1B-adrenergic receptors. J Am Coll Cardiol 38: 534-540.
27. Iaccarino G, Smithwick LA, Lefkowitz RJ, Koch WJ (1999). Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis. Proc Natl Acad Sci USA 96: 3945-3950.
28. Iaccarino G, Tomhave ED, Lefkowitz RJ, Koch WJ (1998). Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade. Circulation 98: 1783-1789.
29. Kanda S, Miyata Y, Kanetake H (2004). Role of focal adhesion formation in migration and morphogenesis of endothelial cells. Cell Signal 16: 1273-1281.
30. Koller A, Huang A, Sun D, Kaley G (1995). Exercise training augments flow-dependent dilation in rat skeletal muscle arterioles. Role of endothelial nitric oxide and prostaglandins. Circ Res 76: 544-550.
31. Lanni F, Santulli G, Izzo R, Rubattu S, Zanda B, Volpe M et al. (2007).The Pl(A1/A2) polymorphism of glycoprotein IIIa and cerebrovascular events in hypertension: increased risk of ischemic stroke in high-risk patients. J Hypertens 25: 551-556.
32. le Noble FA, Stassen FR, Hacking WJ, Struijker Boudier HA (1998). Angiogenesis and hypertension. J Hypertens 16: 1563-1572.
33. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P et al. (2003). Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest 111: 1853-1862.
34. Lembo G, Iaccarino G, Vecchione C, Barbato E, Morisco C, Monti F et al. (1997). Insulin enhances endothelial alpha2-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension 30: 1128-1134.
35. Liggett SB (2006). Cardiac 7-transmembrane-spanning domain receptor portfolios: diversify, diversify, diversify. J Clin Invest 116: 875-877.
36. Martin A, Komada MR, Sane DC (2003). Abnormal angiogenesis in diabetes mellitus. Med Res Rev 23: 117-145.
37. McKee AP, Van Riper DA, Davison CA, Singer HA (2003). Genderdependent modulation of alpha 1-adrenergic responses in rat mesenteric arteries. Am J Physiol Heart Circ Physiol 284: H1737-H1743.
38. Michelotti GA, Bauman MJ, Smith MP, Schwinn DA (2003). Cloning and characterization of the rat alpha 1a-adrenergic receptor gene promoter. Demonstration of cell specificity and regulation by hypoxia. J Biol Chem 278: 8693-8705.
39. Morisco C, Marrone C, Trimarco V, Crispo S, Monti MG, Sadoshima J et al. (2007). Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression. Cardiovasc Res 76: 453-464.
40. Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C et al. (1998). Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101: 2567-2578.
41. Papetti M, Herman IM (2002). Mechanisms of normal and tumorderived angiogenesis. Am J Physiol Cell Physiol 282: C947-C970.
42. Picano E, Michelassi C (1997). Chronic oral dipyridamole as a 'novel' antianginal drug: the collateral hypothesis. Cardiovasc Res 33: 666-670.
43. Price RJ, Skalak TC (1996). Chronic alpha 1-adrenergic blockade stimulates terminal and arcade arteriolar development. Am J Physiol 271: H752-H759.
44. Rocnik EF, Liu P, Sato K, Walsh K, Vaziri C (2006). The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J Biol Chem 281: 22855-22864.
45. Seko Y, Imai Y, Suzuki S, Kamijukkoku S, Hayasaki K, Sakomura Y et al. (1997). Serum levels of vascular endothelial growth factor in patients with acute myocardial infarction undergoing reperfusion therapy. Clin Sci (Lond) 92: 453-454.
46. Takeshita S, Zheng LP, Brogi E, Kearney M, Pu LQ, Bunting S et al. (1994). Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 93: 662-670.
47. Tuttle JL, Falcone JC (2001). Nitric oxide release during alpha1-adrenoceptor-mediated constriction of arterioles. Am J Physiol Heart Circ Physiol 281: H873-H881.
48. Yamauchi J, Itoh H, Shinoura H, Miyamoto Y, Hirasawa A, Kaziro Y et al. (2001). Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in alpha1B-adrenergic receptor/ Galphaq-induced inhibition of cell proliferation. Biochem Biophys Res Commun 281: 1019-1023.
49. Zhou A, Egginton S, Hudlicka O, Brown MD (1998). Internal division of capillaries in rat skeletal muscle in response to chronic vasodilator treatment with alpha1-antagonist prazosin. Cell Tissue Res 293: 293-303.
50. Zou MX, Roy AA, Zhao Q, Kirshenbaum LA, Karmazyn M, Chidiac P (2006). RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes. Cell Signal 18: 1655-1663.